Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Yonsei University
Up to now, 24 patients with major depression and 6 normal controls are enrolled. Twenty-three patients and 4 normal participants have taken 10 days rTMS. One patients and one control withdrew their consent without any reason and one control withdrew the consent because of headache.
We scanned fMRIs(to examine functional connectivity)twice for each participant, which were taken 3 days before the first and 3 days after the last rTMS.
All of participants have not reported side effects except mild headahe. There's been no seizure event up to now.
Age
19–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
DSM-IV major depressive episode
Failure of at least 3 different kind of antidepressant
You may not be if
Organic brain disorder
Other diagnosis of DMS-IV except nicotine dependence